ZyVersa Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$2.20 | -$2.20 | -$2.20 |
| Q2 2024 | 1 | -$1.60 | -$1.60 | -$1.60 |
| Q3 2024 | 1 | -$2.73 | -$2.73 | -$2.73 |
| Q1 2025 | 1 | -$0.40 | -$0.40 | -$0.40 |
| Q2 2025 | 1 | -$0.40 | -$0.40 | -$0.40 |
| Q3 2025 | 1 | -$0.25 | -$0.25 | -$0.25 |
| Q4 2025 | 1 | -$0.30 | -$0.30 | -$0.30 |
ZyVersa Therapeutics, Inc. Earnings Date And Information
ZyVersa Therapeutics, Inc. last posted its earnings results on Thursday, November 14th, 2024. The company reported $-2.43 earnings per share for the quarter, topping analysts' consensus estimates of $-5.8 by $3.37. The company had revenue of 0 for the quarter and had revenue of 0 for the year. ZyVersa Therapeutics, Inc. has generated $-1,090 earnings per share over the last year ($-1089.67 diluted earnings per share) and currently has a price-to-earnings ratio of -0. ZyVersa Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 24th, 2025 based on prior year's report dates.
ZyVersa Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$5.80 | -$0.24 | 5.56 | $0 | $0 |
| 08/09/2024 | Q2 2024 | -$5.20 | -$3.31 | 1.89 | $0 | $0 |
| 05/15/2024 | Q1 2024 | -$3.70 | -$4.53 | -0.83 | $0 | |
| 05/15/2024 | Q4 2023 | -$3.70 | -$32.92 | -29.22 | $15,600 | |
| 09/29/2023 | Q3 2023 | -$33.16 | $0 | |||
| 08/21/2023 | Q2 2023 | -$1,694.14 | $0 | |||
| 05/12/2023 | Q1 2023 | -$135.88 | $0 | |||
| 03/31/2023 | Q4 2022 | -$180.25 | $0 | |||
| 09/30/2022 | Q3 2022 | -$287.36 | $0 | |||
| 08/15/2022 | Q2 2022 | -$50.17 | $0 | |||
| 05/12/2022 | Q1 2022 | -$80.52 | $0 | |||
| 12/31/2021 | Q4 2021 | -$8.33 | $0 | |||
| 09/30/2021 | Q3 2021 | -$40.38 | $0 | |||
| 06/29/2021 | Q2 2021 | -$45.00 | $0 | |||
| 03/30/2021 | Q1 2021 | -$45.97 | $0 |
ZyVersa Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is ZyVersa Therapeutics, Inc.'s earnings date?
ZyVersa Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 24th, 2025 based off last year's report dates.
-
Did ZyVersa Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, ZyVersa Therapeutics, Inc. (:ZVSA) reported $-2.43 earnings per share (EPS) to beat the analysts' consensus estimate of $-5.8 by $3.37.
-
How can I listen to ZyVersa Therapeutics, Inc.'s earnings conference call?
The conference call for ZyVersa Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read ZyVersa Therapeutics, Inc.'s conference call transcript?
The conference call transcript for ZyVersa Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does ZyVersa Therapeutics, Inc. generate each year?
ZyVersa Therapeutics, Inc. (:ZVSA) has a recorded net income of $0. ZyVersa Therapeutics, Inc. has generated $-1089.67 earnings per share over the last four quarters.
-
What is ZyVersa Therapeutics, Inc.'s price-to-earnings ratio?
ZyVersa Therapeutics, Inc. (:ZVSA) has a price-to-earnings ratio of -0 and price/earnings-to-growth ratio is 0.
